U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H22FN3O2S
Molecular Weight 411.492
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ALTANSERIN

SMILES

FC1=CC=C(C=C1)C(=O)C2CCN(CCN3C(=S)NC4=C(C=CC=C4)C3=O)CC2

InChI

InChIKey=SMYALUSCZJXWHG-UHFFFAOYSA-N
InChI=1S/C22H22FN3O2S/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29)

HIDE SMILES / InChI
Molecular Formula C22H22FN3O2S
Molecular Weight 411.492
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:31:32 UTC 2023
Edited
by admin
on Sat Dec 16 16:31:32 UTC 2023
Record UNII
5015H744JQ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ALTANSERIN
INN   WHO-DD  
INN  
Official Name English
3-(2-(4-(P-FLUOROBENZOYL)PIPERIDINO)ETHYL)-2-THIO-2,4(1H,3H)-QUINAZOLINEDIONE
Common Name English
Altanserin [WHO-DD]
Common Name English
4(1H)-QUINAZOLINONE, 3-(2-(4-(4-FLUOROBENZOYL)-1-PIPERIDINYL)ETHYL)-2,3-DIHYDRO-2-THIOXO-
Systematic Name English
altanserin [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C66885
Created by admin on Sat Dec 16 16:31:32 UTC 2023 , Edited by admin on Sat Dec 16 16:31:32 UTC 2023
Code System Code Type Description
NCI_THESAURUS
C77258
Created by admin on Sat Dec 16 16:31:32 UTC 2023 , Edited by admin on Sat Dec 16 16:31:32 UTC 2023
PRIMARY
EVMPD
SUB05375MIG
Created by admin on Sat Dec 16 16:31:32 UTC 2023 , Edited by admin on Sat Dec 16 16:31:32 UTC 2023
PRIMARY
MESH
C071983
Created by admin on Sat Dec 16 16:31:32 UTC 2023 , Edited by admin on Sat Dec 16 16:31:32 UTC 2023
PRIMARY
ChEMBL
CHEMBL62919
Created by admin on Sat Dec 16 16:31:32 UTC 2023 , Edited by admin on Sat Dec 16 16:31:32 UTC 2023
PRIMARY
INN
5395
Created by admin on Sat Dec 16 16:31:32 UTC 2023 , Edited by admin on Sat Dec 16 16:31:32 UTC 2023
PRIMARY
ECHA (EC/EINECS)
278-422-1
Created by admin on Sat Dec 16 16:31:32 UTC 2023 , Edited by admin on Sat Dec 16 16:31:32 UTC 2023
PRIMARY
FDA UNII
5015H744JQ
Created by admin on Sat Dec 16 16:31:32 UTC 2023 , Edited by admin on Sat Dec 16 16:31:32 UTC 2023
PRIMARY
CAS
76330-71-7
Created by admin on Sat Dec 16 16:31:32 UTC 2023 , Edited by admin on Sat Dec 16 16:31:32 UTC 2023
PRIMARY
PUBCHEM
3033677
Created by admin on Sat Dec 16 16:31:32 UTC 2023 , Edited by admin on Sat Dec 16 16:31:32 UTC 2023
PRIMARY
SMS_ID
100000087474
Created by admin on Sat Dec 16 16:31:32 UTC 2023 , Edited by admin on Sat Dec 16 16:31:32 UTC 2023
PRIMARY
EPA CompTox
DTXSID5043891
Created by admin on Sat Dec 16 16:31:32 UTC 2023 , Edited by admin on Sat Dec 16 16:31:32 UTC 2023
PRIMARY
WIKIPEDIA
ALTANSERIN
Created by admin on Sat Dec 16 16:31:32 UTC 2023 , Edited by admin on Sat Dec 16 16:31:32 UTC 2023
PRIMARY
Related Record Type Details
Structure of ALTANSERIN F-18
LABELED -> NON-LABELED
Structure of DEUTEROALTANSERIN F-18
LABELED -> NON-LABELED
Structure of ALTANSERIN TARTRATE
SALT/SOLVATE -> PARENT
Related Record Type Details
Structure of ALTANSERIN
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966